StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMJun 29, 2026, 04:07 PM

AnaptysBio Schedules 2026 Annual Meeting, Outlines Proposals

AI Summary

AnaptysBio, Inc. has scheduled its 2026 Annual Meeting of Stockholders for August 11, 2026. Stockholders of record as of June 22, 2026, will vote on several key proposals, including the election of two Class III directors, the ratification of KPMG LLP as the independent auditor, and a non-binding advisory vote on executive compensation. Additionally, stockholders will consider an amendment to the company's 2017 Equity Incentive Plan. Proxy materials were made available to stockholders on or about June 29, 2026.

Key Highlights

  • 2026 Annual Meeting of Stockholders scheduled for Tuesday, August 11, 2026, at 9:00 a.m. Pacific Time.
  • Record date for voting is June 22, 2026, with 29,608,481 shares of common stock outstanding.
  • Proposals include the election of two Class III directors, Hollings Renton and John P. Schmid.
  • Stockholders will vote to ratify KPMG LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2027.
  • A non-binding advisory vote on the compensation of named executive officers will be conducted.
  • Approval of an amendment to the 2017 Equity Incentive Plan is also on the agenda.
  • Proxy materials, including the proxy statement and 2025 Annual Report on Form 10-K, are available online from June 29, 2026.